These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 20699197)

  • 21. Lack of evident atherosclerosis despite multiple risk factors in glycogen storage disease type 1a with hyperadiponectinemia.
    Tamaki M; Tamura Y; Ogihara T; Shimizu T; Uchino H; Hirose T; Kawamori R; Watada H
    Metabolism; 2007 Oct; 56(10):1402-4. PubMed ID: 17884452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A review of genetic causes of ischemic and hemorrhagic stroke.
    Tonk M; Haan J
    J Neurol Sci; 2007 Jun; 257(1-2):273-9. PubMed ID: 17328915
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stone forming risk factors in patients with type Ia glycogen storage disease.
    Scales CD; Chandrashekar AS; Robinson MR; Cantor DA; Sullivan J; Haleblian GE; Leitao VA; Sur RL; Borawski KM; Koeberl D; Kishnani PS; Preminger GM
    J Urol; 2010 Mar; 183(3):1022-5. PubMed ID: 20092831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Living donor liver transplantation for glycogen storage disease type Ib.
    Kasahara M; Horikawa R; Sakamoto S; Shigeta T; Tanaka H; Fukuda A; Abe K; Yoshii K; Naiki Y; Kosaki R; Nakagawa A
    Liver Transpl; 2009 Dec; 15(12):1867-71. PubMed ID: 19938129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Risk factors of acute and chronic cerebral ischemia].
    Burtsev EM; Shprakh VV; Osipova NF
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(1):16-20. PubMed ID: 2158717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prior antiplatelet use and infarct volume in ischemic stroke.
    Ovbiagele B; Buck BH; Liebeskind DS; Starkman S; Bang OY; Ali LK; Villablanca JP; Salamon N; Yun SW; Pineda S; Saver JL
    J Neurol Sci; 2008 Jan; 264(1-2):140-4. PubMed ID: 17854835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased scavenger receptor class B type I-mediated cellular cholesterol efflux and antioxidant capacity in the sera of glycogen storage disease type Ia patients.
    Nguyen AD; Pan CJ; Weinstein DA; Chou JY
    Mol Genet Metab; 2006 Nov; 89(3):233-8. PubMed ID: 16777453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neutropenia, neutrophil dysfunction, and inflammatory bowel disease in glycogen storage disease type Ib: results of the European Study on Glycogen Storage Disease type I.
    Visser G; Rake JP; Fernandes J; Labrune P; Leonard JV; Moses S; Ullrich K; Smit GP
    J Pediatr; 2000 Aug; 137(2):187-91. PubMed ID: 10931410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Neutropenia in glycogenesis I B].
    Faraci C; Ianniello A; Sesini E; Milesi S; Galmozzi A
    Pediatr Med Chir; 1984; 6(4):535-7. PubMed ID: 6598220
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glycogen storage disease: clinical, biochemical, and molecular heterogeneity.
    Shin YS
    Semin Pediatr Neurol; 2006 Jun; 13(2):115-20. PubMed ID: 17027861
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation of coronary artery atherosclerosis with atherosclerosis of the intracranial cerebral artery and the extracranial carotid artery.
    Seo WK; Yong HS; Koh SB; Suh SI; Kim JH; Yu SW; Lee JY
    Eur Neurol; 2008; 59(6):292-8. PubMed ID: 18408369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term results of living donor liver transplantation for glycogen storage disorders in children.
    Iyer SG; Chen CL; Wang CC; Wang SH; Concejero AM; Liu YW; Yang CH; Yong CC; Jawan B; Cheng YF; Eng HL
    Liver Transpl; 2007 Jun; 13(6):848-52. PubMed ID: 17539004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatocellular adenoma and metabolic balance in patients with type Ia glycogen storage disease.
    Di Rocco M; Calevo MG; Taro' M; Melis D; Allegri AE; Parenti G
    Mol Genet Metab; 2008 Apr; 93(4):398-402. PubMed ID: 18083610
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ASCO classification in clinical practice.
    Degirmenci E; Erdogan C; Oguzhanoglu A; Bir LS
    Ideggyogy Sz; 2013 Jan; 66(1-2):58-62. PubMed ID: 23607231
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glucose-6-phosphate: a key compound in glycogenosis I and favism leading to hyper- or hypolipidaemia.
    Schmitz G; Hohage H; Ullrich K
    Eur J Pediatr; 1993; 152 Suppl 1():S77-84. PubMed ID: 8319730
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Guidelines for management of glycogen storage disease type I - European Study on Glycogen Storage Disease Type I (ESGSD I).
    Rake JP; Visser G; Labrune P; Leonard JV; Ullrich K; Smit GP;
    Eur J Pediatr; 2002 Oct; 161 Suppl 1():S112-9. PubMed ID: 12373584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenome-Wide Association Study Indicates Hypomethylation of MTRNR2L8 in Large-Artery Atherosclerosis Stroke.
    Shen Y; Peng C; Bai Q; Ding Y; Yi X; Du H; He L; Zhou D; Chen X
    Stroke; 2019 Jun; 50(6):1330-1338. PubMed ID: 31084332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cause and mechanisms of intracranial atherosclerosis.
    Ritz K; Denswil NP; Stam OC; van Lieshout JJ; Daemen MJ
    Circulation; 2014 Oct; 130(16):1407-14. PubMed ID: 25311618
    [No Abstract]   [Full Text] [Related]  

  • 39. [Characteristics of lipid metabolism and the cardiovascular system in glycogenosis types I and III].
    Polenova NV; Strokova TV; Starodubova AV
    Ter Arkh; 2017; 89(8):88-94. PubMed ID: 28914857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Consensus guidelines for management of glycogen storage disease type 1b - European Study on Glycogen Storage Disease Type 1.
    Visser G; Rake JP; Labrune P; Leonard JV; Moses S; Ullrich K; Wendel U; Smit GP;
    Eur J Pediatr; 2002 Oct; 161 Suppl 1():S120-3. PubMed ID: 12373585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.